Bortezomib After Combination Chemotherapy, Rituximab, and an Autologous Stem Cell Transplant in Treating Patients With Mantle Cell Lymphoma

NCT00310037 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

151

Enrollment

OTHER

Sponsor class

Conditions

Mantle Cell Lymphoma

Interventions

DRUG: bortezomib

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]
[object Object]